RMD Stock Benefits From the Launch of NightOwl Across US [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
NightOwl is an FDA-cleared home sleep apnea test (HSAT), designed to offer healthcare providers a simplified, accurate, and efficient way to diagnose obstructive sleep apnea (OSA) from an individual's home. HSAT is expected to bolster the company's core sleep apnea and respiratory care business. Following the announcement, shares of RMD grew marginally 0.3% during the after-market trading session yesterday. Meanwhile, over the past year, RMD's shares have gained 15.4% compared with the industry's 11.3% growth. The S&P 500 has increased 10.8% in the same time frame. The company has been ramping up its demand-generation initiatives to raise awareness and create care pathways for patients suffering from sleep suffocation across specific global markets. The latest launch represents a pivotal step in Resmed's strategy to deliver life-changing sleep and breathing health technology. Hence, we expect the latest development to boost the market sentiment toward RMD stock. Resmed present
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed (NYSE:RMD) was given a new $275.00 price target on by analysts at Robert W. Baird.MarketBeat
- ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Top 50 High-Quality Dividend Growth Stocks For December 2025 [Seeking Alpha]Seeking Alpha
- Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP TherapyGlobeNewswire
- Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines? [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 10/30/25 - Beat
RMD
Sec Filings
- 12/9/25 - Form 4
- 12/8/25 - Form 144
- 12/4/25 - Form 4
- RMD's page on the SEC website